Press Releases

---

February 2, 2026 EmeritusDX Expands National Footprint With New Laboratory Operations in Fort Worth, (pdf)

January 12, 2026 EmeritusDX Announces Major Expansion With New 26,000 Square Foot National Headquart (pdf)

June 3, 2024 EmeritusDX Continues Expansion, Announces New Director of Sales for Central US (pdf)

April 8,2024 EmeritusDX Announces Launch of FDA Approved Therascreen BRAF and KRAS Tests (pdf)

February 28, 2024EmeritusDX Receives Clinical Laboratory Permit from New York State (pdf)

October 11, 2023 - Biocare and EmeritusDX Integrate Intellipath System (pdf)

August 28, 2023 EmeritusDX Expands Operations With New 10,000 sqft State-of-the-Art Laboratory (pdf)

July 17, 2023 - AccuStem Sciences and EmeritusDX Announce Strategic Partnership (pdf)

May 24, 2023 EmeritusDX Announces Launch of New Molecular Test, MetaDX™ (pdf)

March 3, 2023 EmeritusDX Launches Innovative Test for Sexually Transmitted Infections (pdf)

February 22, 2023 EmeritusDX Announces Expansion of National Sales Team (pdf)

November 7, 2022 EmeritusDX and KDx Diagnostics Inc. Announce a Partnership (pdf)

June 13, 2022 EmeritusDX Announces Acquisition of Freedom Pathology Partners (pdf)

January 27, 2022 EmeritusDX Announces Launch of UTIDX™ to Advance Patient Care in Urology (pdf)

January 20, 2021 Robert Embree and Jason Allchin Team Up to Start EmeritusDX (pdf)